drugset / Trial / NCT02632760
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Phase 4
Completed
955 enrolled
Bayside Health
Monash University · collabNational Health and Medical Research Council, Australia · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This randomised double-blind, controlled phase IV trial will compare the efficacy, safety and cost-effectiveness of preoperative IV iron with placebo in patients with anaemia before elective cardiac surgery.
Timeline
- Start
- 2016-07-15
- Primary completion
- 2024-04-16
- Completion
- 2024-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | 1000 mg | Intravenous |
| Subject | Iron isomaltoside 1000 | Unknown | 1000 mg | Intravenous |